Literature DB >> 22327571

Anti-aquaporin-4 antibody-positive recurrent isolated optic neuritis and primary Sjögren's syndrome.

Giulia Mallucci, Diego Franciotta, Alfredo Romani, Mauro Ceroni, Roberto Bergamaschi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22327571     DOI： 10.1007/s00415-012-6434-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  EFNS guidelines on diagnosis and management of neuromyelitis optica.

Authors:  J Sellner; M Boggild; M Clanet; R Q Hintzen; Z Illes; X Montalban; R A Du Pasquier; C H Polman; P S Sorensen; B Hemmer
Journal:  Eur J Neurol       Date:  2010-06-07       Impact factor: 6.089

3.  Primary Sjögren's syndrome initially manifested by optic neuritis: MRI findings.

Authors:  Y Kadota; A M Tokumaru; K Kamakura; S Kohyama; H Okizuka; T Kaji; S Kusano
Journal:  Neuroradiology       Date:  2002-02-16       Impact factor: 2.804

Review 4.  Neurological manifestations of primary Sjogren's syndrome.

Authors:  Josiah Chai; Eric L Logigian
Journal:  Curr Opin Neurol       Date:  2010-10       Impact factor: 5.710

5.  Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.

Authors:  Sven Jarius; Jette Frederikson; Patrick Waters; Friedemann Paul; Gulsen Akman-Demir; Romain Marignier; Diego Franciotta; Klemens Ruprecht; Bettina Kuenz; Paulus Rommer; Wolfgang Kristoferitsch; Brigitte Wildemann; Angela Vincent
Journal:  J Neurol Sci       Date:  2010-09-18       Impact factor: 3.181

6.  Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.

Authors:  Sven Jarius; Christian Jacobi; Jerome de Seze; Helene Zephir; Friedemann Paul; Diego Franciotta; Paulus Rommer; Simone Mader; Ingo Kleiter; Markus Reindl; Gulsen Akman-Demir; Thomas Seifert-Held; Wolfgang Kristoferitsch; Arthur Melms; Klaus-Peter Wandinger; Brigitte Wildemann
Journal:  Mult Scler       Date:  2011-05-04       Impact factor: 6.312

Review 7.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

8.  NMO-IgG predicts the outcome of recurrent optic neuritis.

Authors:  M Matiello; V A Lennon; A Jacob; S J Pittock; C F Lucchinetti; D M Wingerchuk; B G Weinshenker
Journal:  Neurology       Date:  2008-04-23       Impact factor: 9.910

9.  Neuromyelitis optica and non organ-specific autoimmunity.

Authors:  Sean J Pittock; Vanda A Lennon; Jerome de Seze; Patrick Vermersch; Henry A Homburger; Dean M Wingerchuk; Claudia F Lucchinetti; Hélène Zéphir; Kevin Moder; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2008-01
  9 in total
  1 in total

1.  Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma.

Authors:  Michele Colaci; Giulia Cassone; Andreina Manfredi; Marco Sebastiani; Dilia Giuggioli; Clodoveo Ferri
Journal:  Case Rep Neurol Med       Date:  2014-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.